AI Article Synopsis

  • The use of selective serotonin reuptake inhibitors (SSRIs), like sertraline, can lead to mild to severe spontaneous bleeding, although the exact cause is unclear.
  • A case report highlights a 44-year-old woman with anxiety disorder who experienced periorbital purpura while on sertraline, suggesting a potential connection between SSRIs and bleeding risks.
  • To mitigate these risks, it's suggested that non-SSRI alternatives should be considered for treatment, and further research is necessary to explore SSRIs' impact on bleeding and hemostasis.

Article Abstract

Objective: The incidence of mild to severe levels of spontaneous bleeding due to the usage of selective serotonin reuptake inhibitors (SSRIs) is relatively low. Although the exact mechanism is not known, it is thought that inhibition of the serotonin transporter together with a decrease in platelet serotonin could be responsible for the bleeding. Therefore, the use of SSRIs in conjunction with anti-aggregants may predispose to or exacerbate the risk of bleeding. In this case report, we describe a 44-year-old female patient with a diagnosis of anxiety disorder who spontaneously developed periorbital purpura during treatment with sertraline.

Conclusion: Abnormal bleeding after treatment with an SSRI should be kept in mind, and alternative non-SSRI drugs of choice in such cases would be more appropriate. More extensive and comprehensive studies focusing on hemostasis and bleeding disorders are needed for SSRIs such as sertraline.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1039856215586138DOI Listing

Publication Analysis

Top Keywords

periorbital purpura
8
case report
8
bleeding
5
sertraline-induced periorbital
4
purpura case
4
report objective
4
objective incidence
4
incidence mild
4
mild severe
4
severe levels
4

Similar Publications

Background: Primary light chain amyloidosis is a rare and complex disease with complex clinical features and is highly susceptible to misdiagnosis and underdiagnosis in the early stages.

Case Summary: We report a case of a 47-year-old female patient whose only initial symptom was periorbital purpura, which was not taken seriously enough. As the disease progressed, pleural effusion gradually appeared, and after systematic diagnosis and treatment, she was diagnosed with "primary light chain amyloidosis".

View Article and Find Full Text PDF

Immunoglobulin A (IgA) vasculitis, or Henoch-Schonlein purpura, is the most common systemic vasculitis in children, clinically presenting as palpable purpura in combination with arthritis, gastrointestinal involvement, or kidney injury. Subcutaneous edema is reported in patients with IgA vasculitis, and it commonly affects the lower extremities, especially around joints. Here, we report a case of IgA vasculitis with a rare presentation of edema isolated to the periorbital area in a 7-year-old boy, who subsequently developed crescentic glomerulonephritis with nephrotic range proteinuria.

View Article and Find Full Text PDF

Despite low prevalence of leprosy worldwide, new cases continue to present and require swift evaluation and diagnosis to prevent complications. Here, we describe a case of lepromatous leprosy with Lucio's phenomenon initially presenting with facial and periorbital edema. A 38-year-old Brazilian woman presented to the emergency department with facial swelling and erythema, initially treated as cellulitis.

View Article and Find Full Text PDF

Immune thrombocytopenia (ITP) is an immune-mediated event, characterised by the destruction of platelets by autoantibodies resulting in isolated thrombocytopaenia (platelets <100 x10/L). In children, most cases are preceded by a viral infection. Cases of ITP in the setting of SARS-CoV-2 infection have been described.

View Article and Find Full Text PDF

Hereditary transthyretin amyloidosis presenting with spontaneous periorbital purpura: a case report.

Eur Heart J Case Rep

March 2023

Department of Advanced Heart Failure and Transplantation, Mayo Clinic, 4500 San Pablo Road S, Jacksonville, FL 32234, USA.

Background: Amyloidosis is a systemic disorder of abnormal protein folding and deposition resulting in a range of symptoms including neuropathy, heart failure, renal disease, and dermatologic findings. The two most common types of amyloidosis that affect the heart are transthyretin (ATTR) amyloidosis and light chain (AL) amyloidosis, which vary in clinical presentation. Skin findings such as periorbital purpura are considered more specific for AL amyloidosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!